Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Schmidt

Showing results (251-260 of 344) with videos related to

Pageof 35
Sort By:
Journal of Integrative Bioinformatics|May 15, 2026
The community engagement and empowerment cycle: FAIRagro's framework to foster cultural change towards FAIR RDM practices in agrosystem science and beyondAnne Sennhenn, James M Anderson, Sophie Boße, et al.
Frontiers in Oncology|October 3, 2022
Impact of perioperative red blood cell transfusion, anemia of cancer and global health status on the prognosis of elderly patients with endometrial and ovarian cancerKatharina Anic, Mona Wanda Schmidt, Marcus Schmidt, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2022
Long-term prognostic significance of HER2-low and HER2-zero in node-negative breast cancerKatrin Almstedt, Anne-Sophie Heimes, Franziska Kappenberg, et al.
Dalton Transactions (Cambridge, England : 2003)|August 12, 2014
Oxygen-driven competition between low-dimensional structures of Sr3CoMO6 and Sr3CoMO7-δ with M = Ru, IrDaria Mikhailova, Phillip Reichel, Alexander A Tsirlin, et al.
Breast (Edinburgh, Scotland)|June 18, 2022
A nested case-control study on radiation dose-response for cardiac events in breast cancer patients in GermanyDan Baaken, Hiltrud Merzenich, Marcus Schmidt, et al.
Breast (Edinburgh, Scotland)|March 21, 2026
Sentinel lymph node detection in early-stage breast cancer - Are technetium-99m-nanocolloid and superparamagnetic iron oxide diagnostically equivalent procedures? A propensity score matched real world data analysisIna Shehaj, Katharina Stuppy, Amelie Löwe, et al.
ACS Organic & Inorganic Au|February 9, 2026
Unusual Magnetic Order in Eu<sub>11-<i>x</i></sub> Hg<sub>54+<i>x</i></sub>Rachel Nixon, Nazar Zaremba, Samuel A Adegboyega, et al.
Plos One|October 3, 2012
Immunoglobulin kappa C predicts overall survival in node-negative breast cancerZonglin Chen, Aslihan Gerhold-Ay, Susanne Gebhard, et al.
International Journal of Cancer|March 6, 2024
Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO studyDiana Lüftner, Florian Schuetz, Andreas Schneeweiss, et al.
Breast Cancer Research and Treatment|July 20, 2020
Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1, TRIO-18)Richard S Finn, Katalin Boer, Igor Bondarenko, et al.
Pageof 35

Showing results (251-260 of 344) with videos related to

Sort By:
Pageof 35
Journal of Integrative Bioinformatics|May 15, 2026
The community engagement and empowerment cycle: FAIRagro's framework to foster cultural change towards FAIR RDM practices in agrosystem science and beyondAnne Sennhenn, James M Anderson, Sophie Boße, et al.
Frontiers in Oncology|October 3, 2022
Impact of perioperative red blood cell transfusion, anemia of cancer and global health status on the prognosis of elderly patients with endometrial and ovarian cancerKatharina Anic, Mona Wanda Schmidt, Marcus Schmidt, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2022
Long-term prognostic significance of HER2-low and HER2-zero in node-negative breast cancerKatrin Almstedt, Anne-Sophie Heimes, Franziska Kappenberg, et al.
Dalton Transactions (Cambridge, England : 2003)|August 12, 2014
Oxygen-driven competition between low-dimensional structures of Sr3CoMO6 and Sr3CoMO7-δ with M = Ru, IrDaria Mikhailova, Phillip Reichel, Alexander A Tsirlin, et al.
Breast (Edinburgh, Scotland)|June 18, 2022
A nested case-control study on radiation dose-response for cardiac events in breast cancer patients in GermanyDan Baaken, Hiltrud Merzenich, Marcus Schmidt, et al.
Breast (Edinburgh, Scotland)|March 21, 2026
Sentinel lymph node detection in early-stage breast cancer - Are technetium-99m-nanocolloid and superparamagnetic iron oxide diagnostically equivalent procedures? A propensity score matched real world data analysisIna Shehaj, Katharina Stuppy, Amelie Löwe, et al.
ACS Organic & Inorganic Au|February 9, 2026
Unusual Magnetic Order in Eu<sub>11-<i>x</i></sub> Hg<sub>54+<i>x</i></sub>Rachel Nixon, Nazar Zaremba, Samuel A Adegboyega, et al.
Plos One|October 3, 2012
Immunoglobulin kappa C predicts overall survival in node-negative breast cancerZonglin Chen, Aslihan Gerhold-Ay, Susanne Gebhard, et al.
International Journal of Cancer|March 6, 2024
Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO studyDiana Lüftner, Florian Schuetz, Andreas Schneeweiss, et al.
Breast Cancer Research and Treatment|July 20, 2020
Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1, TRIO-18)Richard S Finn, Katalin Boer, Igor Bondarenko, et al.
Pageof 35